With a cohort of 86 randomly selected HCC patients, we investigated the potential downregulation of the LEPREL1 with numerous clinical parameters, including age, gender, tumor size, Edmondson grade, vascular invasion, and AFP. The gene discussed is AFP; the disease is neoplasm.